Griseofulvin versus terbinafine in the treatment of tinea capitis: A meta-analysis of randomized, clinical trials

Pediatrics

Volumn 114, Issue 5, 2004, Pages 1312-1315

  Fleece, David ^a,b   Gaughan, John P ^a   Aronoff, Stephen C ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Griseofulvin; Meta analysis; Microsporum; Terbinafine; Tinea capitis; Trichophyton

Indexed keywords

GRISEOFULVIN; TERBINAFINE; ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA BASE; DERMATOPHYTE; HUMAN; MANTEL HAENSZEL TEST; MEDLINE; META ANALYSIS; MICROSPORUM; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCALP; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK;

ANTIFUNGAL AGENTS; GRISEOFULVIN; HUMANS; NAPHTHALENES; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; TINEA CAPITIS; TREATMENT OUTCOME;

EID: 15444376784     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0428     Document Type: Review

References (16)

1. Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics. 1995;96:265-267
2. Ghannoum M, Isham N, Hajjeh R, et al. Tinea capitis in Cleveland: survey of elementary school students. J Am Acad Dermatol. 2003;48:189-193
3. Wilmington M, Aly R, Frieden IJ. Trichophyton tonsurans tinea capitis in the San Francisco Bay area: increased infection demonstrated in a 20-year survey of fungal infections from 1974 to 1994. J Med Vet Mycol. 1996;34:285-287
4. Weitzman I, Chin NX, Kunjukunju N, Della-Latta P. A survey of dermatophytes isolated from human patients in the United States from 1993 to 1995. J Am Acad Dermatol. 1998;39:255-261
5. Friedlander SF. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. Pediatr Infect Dis J. 1999;18:205-210
6. Agresti A. An Introduction to Categorical Data Analysis. New York, NY: John Wiley & Sons; 1996:53-66
7. Lipozencic J, Skerlev M, Orofino-Costa R, et al. A randomized, doubleblind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol. 2002;146:816-823
8. Fuller LC, Smith CH, Cerio R, et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol. 2001;144:321-327
9. Gupta AK, Adam P, Dlova N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol. 2001;18:433-438
10. Cáceres-Ríos H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol. 2000;42:80-84
11. Memişoĝlu HR, Erboz S, Akkaya S, et al. Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis. J Dermatol Treat. 1999;10:189-193
12. Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children. N Z Med J. 1998;111:55-57
13. Haroon TS, Hussein I, Aman S, et al. A randomized double-blind, comparative study of terbinafine vs griseofulvin in tinea capitis. J Dermatol Treat. 1995;3:167-169
14. Haroon TS, Hussein I, Aman S, et al. A randomized double-blind, comparative study of terbinafine vs griseofulvin in tinea capitis. J Dermatol Treat. 1992;3:25-27
15. Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol. 2000;17:304-309
16. Dragos V, Lunder M. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol. 1997;14:46-48